دورية أكاديمية

The Association Between Short-Acting β2-Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia

التفاصيل البيبلوغرافية
العنوان: The Association Between Short-Acting β2-Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia
المؤلفون: Price, David, Jenkins, Christine, Hancock, Kerry, Vella, Rebecca, Heraud, Florian, Le Cheng, Porsche, Murray, Ruth, Beekman, Maarten, Bosnic-Anticevich, Sinthia, Botini, Fabio, Carter, Victoria, Catanzariti, Angelina, Doan, Joe, Fletton, Kirsty, Kichkin, Ata, Le, Thao, Le Lievre, Chantal, Lau, Chi Ming, Novic, Dominique, Pakos, John, Ranasinghe, Kanchanamala, Roussos, Alexander, Samuel-King, Josephine, Sharma, Anita, Stewart, Deb, Willet, Bruce, Bateman, Eric, Campbell, Rob, Liu, Ying, O’Sullivan, Nicole, Rejda, Ondrej, Sugg, Lisa, James, Steph, Dhillon, Kiran, Jones, Sophie
المساهمون: Optimum Patient Care Australia, AstraZeneca
المصدر: Advances in Therapy ; ISSN 0741-238X 1865-8652
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2024
مصطلحات موضوعية: Pharmacology (medical), General Medicine
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1007/s12325-023-02746-0
DOI: 10.1007/s12325-023-02746-0.pdf
DOI: 10.1007/s12325-023-02746-0/fulltext.html
الإتاحة: https://doi.org/10.1007/s12325-023-02746-0Test
حقوق: https://creativecommons.org/licenses/by-nc/4.0Test ; https://creativecommons.org/licenses/by-nc/4.0Test
رقم الانضمام: edsbas.C29D6BD9
قاعدة البيانات: BASE